Related content

Neurochemical Evidence for Agmatine Modulation of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity

By Gilad Gad   Gilad Varda   Finberg John   Rabey Jose  

Neurochemical Research, Vol. 30, Iss. 6-7, 2005-06 ,pp. : 713-719

Springer Publishing Company

Access to resources Recommend Favorite

Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

By Aguiar Aderbal  

Neurotoxicity Research, Vol. 24, Iss. 2, 2013-08 ,pp. : 280-287

Springer Publishing Company

Access to resources Recommend Favorite

L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates

By Kuoppamäki M.   Al-Barghouthy G.   Jackson M. J.   Smith L. A.   Quinn N.   Jenner P.  

Journal of Neural Transmission, Vol. 114, Iss. 9, 2007-09 ,pp. : 1147-1153

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Behavioral Impairments Correlated to Neurochemical Deficits in Mice Treated with Moderate Doses of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

By Tillerson J.L.   Caudle W.M.   Reverón M.E.   Miller G.W.  

Experimental Neurology, Vol. 178, Iss. 1, 2002-11 ,pp. : 80-90

Academic Press

Access to resources Recommend Favorite

Matrix Metalloproteinase-9 Is Elevated in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism in Mice

By Lorenzl Stefan   Calingasan Noel   Yang Lichuan   Albers David S.   Shugama Shuei   Gregorio Jason   Krell H. W.   Chirichigno Jason   Joh Tong   Beal M. Flint  

NeuroMolecular Medicine, Vol. 5, Iss. 2, 2004-04 ,pp. : 119-132

Humana Press, Inc

Access to resources Recommend Favorite